Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
- 1 January 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 10 (1), 133-142
- https://doi.org/10.1158/1541-7786.mcr-11-0206
Abstract
We previously reported that sterol regulatory element-binding protein-1 (SREBP-1) is involved in the transcriptional regulation of androgen receptor (AR) and formation of fatty acid through altered expression of fatty acid synthase (FASN). In this article, we provide a new finding that SREBP-1 induced oxidative stress in prostate cancer cells through increased production of reactive oxygen species (ROS) and expression of NADPH oxidase 5 (Nox5). We have shown that (i) expression of SREBP-1 protein is positively associated with the clinical Gleason grades in human prostate cancer; (ii) genetic overexpression or knockdown of SREBP-1 in prostate cancer cells resulted in corresponding increased or decreased AR, FASN and Nox5 expression, fatty acid and lipid droplet accumulation, and ROS generation; and (iii) SREBP-1 induces and promotes the growth, migration, invasion, and castration-resistant progression of prostate cancer cells in vitro and in vivo. Our data show a novel molecular mechanism by which SREBP-1 promotes prostate cancer growth and progression through alterations in the concerted intracellular metabolic and signaling networks involving AR, lipogenesis, and ROS in prostate cancer cells. Mol Cancer Res; 10(1); 133–42. ©2011 AACR.Other Versions
This publication has 48 references indexed in Scilit:
- Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cellsThe Prostate, 2010
- Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer CellsOnline Journal of Public Health Informatics, 2010
- Oxidative stress in prostate cancerCancer Letters, 2009
- Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidaseProstate Cancer and Prostatic Diseases, 2009
- Ezetimibe Is an Inhibitor of Tumor AngiogenesisThe American Journal of Pathology, 2009
- β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer CellsClinical Cancer Research, 2008
- Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive PhenotypeCancer Research, 2008
- In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cellsJournal of Cellular Biochemistry, 2004
- Role of oxygen free radicals in cancer developmentEuropean Journal of Cancer, 1996
- On the Origin of Cancer CellsScience, 1956